title: National guidelines for the management of absolute cardiovascular disease risk.
authors.forename: Timothy
authors.initials: T
authors.lastname: Usherwood
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D001315:Australia; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D019468:Disease Management; D004232:Diuretics / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D009313:National Health Programs / Q000458:organization & administration*; D017410:Practice Guidelines as Topic; D011314:Preventive Health Services / Q000592:standards*; D011320:Primary Health Care / Q000592:standards*
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D004232:Diuretics; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors